1.20 USD
↘ 0.80 (40.00%)AT CLOSE (11:59 AM EDT)
Creative Medical Technology Holdings, Inc. Common Stock
CELZNASDAQ • USD
1.20
↘ 0.01 (0.42%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
1.20
↘ 0.01 (0.42%)
Market: CLOSED
Creative Medical Technology Holdings, Inc. Common Stock (CELZ) is currently trading at $1.20. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place CELZ at a fair price relative to peers.
Technical & fundamental data as of Jun 26, 2026.
Open?$1.45
High?$1.55
Low?$1.11
Prev. Close?$2.00
Volume?552.4K
Avg. Volume?66.1K
VWAP?$1.33
Rel. Volume?8.36x
Bid / Ask
Bid?$0.98 × 100
Ask?$1.43 × 100
Spread?$0.45
Midpoint?$1.21
Valuation & Ratios
Market Cap?7.4M
Shares Out?3.7M
Float?3.7M
Float %?99.1%
P/E Ratio?N/A
P/B Ratio?1.21
EPS?-$1.56
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
Employees
4
Market Cap
7.4M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2009-04-30
Address
211 E. OSBORN RD.
PHOENIX, AZ 85012
Phone: 480-399-2822
PHOENIX, AZ 85012
Phone: 480-399-2822
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?50
Piotroski F-Score?0/9Weak
Altman Z-Score?-3.20Distress
Confidence?51%Low
Short InterestLow
Short % of Float?4.23%Low
Short Interest?154.8K
Days to Cover?2.9
Free Float3.7M
Avg Daily Volume53.1K
Settlement Date2026-06-15
Financial Health
Current Ratio?19.69Strong
Quick Ratio?19.29Strong
Cash Ratio?18.60Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?1.21CHEAP▾
Peers100
S&P93
P/S?2,464.45HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-0.3CHEAP▾
S&P97
EV/Sales?556.72HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-94.3%WEAK▾
S&P3
ROA?-89.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$1.7M
Fundamentals ratios updated end of day